Osteoporosis (OP) is a systemic metabolic skeletal disease which can lead to reduction in
bone mass and increased risk of bone fracture due to the microstructural degradation …

Osteoporosis (OP) is a bone disease associated with increasing age. Currently, the most
common medications used to treat OP are anabolic agents, anti-resorptive agents, and …

Eucommia ulmoides Oliver is one of the commonly used traditional Chinese medicines for
the treatment of osteoporosis, and iridoid glycosides are considered to be its active …

The origin of life and native tissue development are dependent on the heterogeneity of
pluripotent stem cells. Bone marrow mesenchymal stem cells (BMMSCs) are located in a …

Osteoporosis is a chronic progressive bone disease characterized by the decreased
osteogenic ability of osteoblasts coupled with increased osteoclast activity. Natural products …

The challenges posed by delayed atrophic healing and nonunion stand as formidable
obstacles in osteoporotic fracture treatment. The processes of type H angiogenesis and …

Senile osteoporosis (SOP) is a systemic bone disease that is significantly associated with
age and eventually leads to deteriorated bone strength and increased fracture risk. Urolithin …

Purpose: As the population ages, there is an increased risk of fracture and morbidity
diseases associated with aging, such as age-related osteoporosis and other bone diseases …

Context Morroniside (MOR) possesses antiosteoporosis (OP) effects, but its molecular target
and relevant mechanisms remain unknown. Objective We investigated the effects of MOR on …

The hyperactivity of osteoclasts caused by postmenopausal estrogen deficiency plays an
imperative role in the progression of osteoporosis. Although osteoporosis-related drugs …